EGFR and neoplasm: Upon removal of the drug, colonies that grew from the DTPs were again sensitive to the EGFR inhibitor, showcasing the innate ability of tumor cells to temporarily adapt to the onslaught of a drug such that the entire population is not eradicated (Sharma et al., 2010).